<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "verapamil inj AMP">
<dose><value>0.1 - 0.2</value>
<value>0.1 - 0.3</value>
<value>2.5 - 5</value>
<value>5 - 10</value>
<value>1 - 5</value>
</dose><route><value>IV</value>
<value>IV </value>
</route><form><value>inj AMP</value>
</form><drugname><value>verapamil inj AMP</value>
</drugname><strength><value>2.5 mg/mL</value>
</strength><frequency><value>ONCE</value>
<value>CONTINUOUS</value>
</frequency><instruction><value>Administer by direct injection over 2 minutes.</value>
<value>Maintenance infusion: Titrate to desired effect.</value>
</instruction><volume><value>2 mL</value>
</volume><units><value>mg/kg/dose</value>
<value>mg</value>
<value>mg/hour</value>
<value>mcg/kg/minute</value>
</units><additionalnotes><value>INFANT (less than 1 year of age):MAXIMUM: 2 mg/dose. Where required, the dose can be repeated 30 minutes after initial dose.</value>
<value>CHILDREN (1 TO 15 years of age):MAXIMUM: 5 mg/dose. Where required, the dose can be repeated 30 minutes after initial dose. MAXIMUM repeat dose: 10mg.</value>
<value>ADULT: If no response and no adverse event, may give 5 to 10 mg every 15 to 30 minutes to a total dose of 20 to 30 mg.</value>
<value>ADULT.</value>
</additionalnotes><population></population><indicationprn></indicationprn><backgroundinformation><value>In patients with hepatic cirrhosis, reduce dose to 20% to 50% of normal dose and monitor BP for hypotension and PR prolongation.</value>
<value>In patients with hepatic cirrhosis, reduce dose to 20% to 50% of normal dose and monitor for abnormal PR prolongation or other adverse effects.</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Calcium-Channel Blocking Agents, Miscellaneous</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>02166739</value>
</din></drug>